Silicone lymphadenopathy after treatment for recurrent triple-negative breast cancer

Patient Info: Anonymized, Female, 50s

Biomarkers: Triple-negative; BRCA1-negative; BRCA2-negative; latest recurrence Ki-67 60%–70%.

At the May 2020 follow-up, biopsies confirmed silicone-related lymph-node changes rather than cancer, and imaging showed no recurrent disease while six-monthly surveillance continued.

PubMed CentralRead more →

Right breast cancer with contralateral axillary lymph-node metastasis

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: Right breast primary: ER-positive; PR-positive; HER2-negative; Ki-67 70%. Left axillary metastasis: ER-positive; PR-negative; HER2-negative; Ki-67 15%; GATA3-positive.

Metastatic Site: contralateral left axillary lymph nodes

Two years after bilateral surgery, clinical and radiological follow-up showed no metastasis or disease recurrence.

PubMed CentralRead more →

Linda Stokes

Patient Info: Linda Stokes, Female

Biomarkers: germline CDH1 mutation

After breast cancer led to discovery of a CDH1 mutation, Linda Stokes chose bilateral mastectomy and later preventive stomach removal.

A difficult breast-reconstruction infection after breast cancer treatment

Patient Info: Anonymized, Female, 40s

After wide debridement and prolonged antibiotic treatment, the breast and abdominal wounds healed, imaging showed resolution of the subcutaneous infection, and no infection recurrence was seen over three years.

PubMed CentralRead more →

Locally advanced male breast cancer associated with a pathogenic ATM variant

Patient Info: Anonymized, Male, 50s | Stage Metastatic/Advanced

Biomarkers: ER 100% positive; PR 100% positive; HER2-negative; Ki-67 30%; germline pathogenic ATM variant c.2921+1G>A.

Two years after diagnosis, he had an ECOG performance status of 0 and remained without signs of breast-cancer relapse or another primary cancer.

PubMed CentralRead more →

A durable response to trastuzumab in heavily pretreated metastatic breast cancer

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: Initial tumor ER-positive and PR-positive. Metastatic liver biopsy ER-negative and PR-negative with HER2 IHC 1+ and nonamplified. Later biopsy ER and PR weakly positive at 5%–10%, HER2 IHC 1+ and nonamplified, and ERBB3 p. with evidence of HER2/HER3 pathway activation.

Metastatic Site: lungs; hilar and mediastinal lymph nodes; liver; bone

She had ongoing benefit for more than 10 months on trastuzumab and capecitabine, with improved symptoms, lower tumor markers, and a confirmed partial response.

PubMed CentralRead more →

Breast Cancer: Maria's Patient Story

Patient Info: Maria

Maria underwent mastectomy, lymph-node surgery, chemotherapy, and radiation and continued to work through fear that the treatment might not succeed.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Marisol's Survivor Story

Patient Info: Marisol | Stage II

Marisol said the breast cancer was in remission after completing most active treatment, and she continued hormone therapy.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Sheryl's Patient Story

Patient Info: Sheryl | Stage II

Sheryl is currently receiving long-term hormone therapy and remains focused on becoming cancer-free.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Erika's Patient Story

Patient Info: Erika, Female, 40s | Stage II

As of 2021, Erika was undergoing treatment for Stage II breast cancer and was on targeted therapy after mastectomy, lymphadenectomy, chemotherapy, and targeted therapy.

Our Cancer StoriesRead more →

Stage I Breast Cancer: Tia's Survivor Story

Patient Info: Tia | Stage I

More than 3 years after her Stage I diagnosis, Tia described herself as in remission and no longer taking medication for breast cancer.

Our Cancer StoriesRead more →

Stage II HR-Positive Breast Cancer: Faith's Survivor Story

Patient Info: Faith, Female, Under 40 | Stage II

Biomarkers: ER-positive; HER2-positive

Faith moved into survivorship after treatment for Stage II ER-positive, HER2-positive breast cancer, with ongoing fear of recurrence but renewed focus on family, nutrition, exercise, and work.

Our Cancer StoriesRead more →

Stage IV Breast Cancer: Harper's Patient Story

Patient Info: Harper, Female, 50s | Stage IV

Harper was living with Stage IV breast cancer after self-funded private treatment that included mastectomy, lymphadenectomy, chemotherapy, and radiation therapy; she felt better than before diagnosis but still hoped for complete recovery.

Our Cancer StoriesRead more →

Breast Cancer: Luz's Survivor Story

Patient Info: Luz

Luz described her breast cancer as being in remission after mastectomy, lymph-node surgery, and chemotherapy, and she remained on hormone therapy.

Our Cancer StoriesRead more →

Rare Tall Cell Breast Carcinoma Treated With Surgery Alone

Patient Info: Anonymized, female, 40s

Biomarkers: Weak ER and PR expression; HER2-negative; IDH2 mutation

No residual tumor or lymph-node involvement was found at completion surgery, PET-CT showed no metastases, and she remained disease-free 6 months after surgery.

PubMed CentralRead more →

Stage II Breast Cancer: Hwee's Patient Story

Patient Info: Hwee Lin, Female, 60s | Stage II

Hwee Lin was receiving targeted therapy for Stage II breast cancer and described the treatment as effective while managing fatigue, hair loss, nausea, and vomiting with medication and improved nutrition.

Our Cancer StoriesRead more →

Breast Cancer: Vivienne's Survivor Story

Patient Info: Vivienne

Vivienne said she was in remission after completing most of her treatment and continued hormone therapy.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Aurora's Patient Story

Patient Info: Aurora, Female, 40s | Stage III

Aurora was treated for Stage III breast cancer with mastectomy, lymphadenectomy, Cytoxan chemotherapy, and radiation therapy, then moved to chemotherapy alone after the initial plan was not working effectively.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Ingrid's Patient Story

Patient Info: Ingrid | Stage II

Ingrid said her stage 2 breast cancer was in remission while she continued a low-toxicity systemic anticancer monotherapy.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Kelly's Patient Story

Patient Info: Kelly, Female, 40s | Stage III

Kelly had Stage III breast cancer diagnosed around 2021, with treatment that included mastectomy, lymphadenectomy, chemotherapy, and radiation therapy; after a treatment change, she was still receiving radiation therapy.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Beth's Survivor Story

Patient Info: Beth, Female, 40s | Stage III

As of 2021, Beth was in remission and no longer taking cancer medication after mastectomy, lymphadenectomy, chemotherapy, radiation therapy, and targeted therapy.

Our Cancer StoriesRead more →

Stage II HER2-Positive Breast Cancer: Kelsey's Survivor Story

Patient Info: Kelsey, Female, 40s | Stage II

Biomarkers: HER2-positive

Kelsey survived Stage II HER2-positive breast cancer after mastectomy, chemotherapy, and targeted therapy, with recovery supported by nutrition changes, massages, supplements, and support-group connection.

Our Cancer StoriesRead more →

Stage I HER2-Positive Breast Cancer: Betty's Survivor Story

Patient Info: Betty, Female, 50s | Stage I

Biomarkers: HER2-positive

As of 2021, Betty was in remission after mastectomy and chemotherapy with Herceptin, while managing side effects such as hair loss, peripheral neuropathy, and weight changes.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Onagh's Survivor Story

Patient Info: Onagh, Female | Stage III

Her stage 3 breast cancer was in complete remission, and she no longer required treatment.

Our Cancer StoriesRead more →